Cochlear Limited
CHEOFOTCHealthcare● Active
$70.86
+$2.81(+4.13%)
Market Cap$4.6B
P/E Ratio—
52W High$207.71
52W Low$64.39
Cochlear Limited (CHEOF) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CHEOF · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 12, 2026EPS Actual
$1.99
Est. $2.10 · -5.2%
Revenue
$0.78B
Est. $0.81B · -3.2%
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 12, 2026
After Market Close
▼ Miss EPS▼ Miss Revenue
CHEOF reports quarterly as a OTC-listed Medical - Devices company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 13, 2026 | $1.23 | — | — | — | $0.84B | — |
| ▼ Q1 FY2026 | Feb 12, 2026 | $2.10 | $1.99 | -5.2% | $0.78B | $0.81B | -3.2% |
| ▼ Q3 FY2025 | Aug 13, 2025 | $1.94 | $1.83 | -5.7% | $0.77B | $0.78B | -1.1% |
| — Q1 FY2025 | Feb 13, 2025 | $1.92 | $1.93 | +0.5% | $0.73B | $0.74B | -1.8% |
| ▼ Q3 FY2024 | Aug 15, 2024 | $2.07 | $1.68 | -18.8% | $0.76B | $0.79B | -3.9% |
| ▲ Q1 FY2024 | Feb 18, 2024 | $1.95 | $1.98 | +1.5% | $0.76B | $0.75B | +0.7% |
| ▼ Q2 FY2023 | Jun 30, 2023 | $1.63 | $1.60 | -1.8% | $0.71B | $0.64B | +10.5% |
| ▲ Q4 FY2022 | Dec 31, 2022 | $1.44 | $1.47 | +2.1% | $0.61B | $0.58B | +4.5% |
Q3 FY2026
Aug 13, 2026
EPS Actual
—
EPS Est.
$1.23
EPS Surpr.
—
Revenue
—
Q1 FY2026
Feb 12, 2026Miss
EPS Actual
$1.99
EPS Est.
$2.10
EPS Surpr.
-5.2%
Revenue
$0.78B
Q3 FY2025
Aug 13, 2025Miss
EPS Actual
$1.83
EPS Est.
$1.94
EPS Surpr.
-5.7%
Revenue
$0.77B
Q1 FY2025
Feb 13, 2025
EPS Actual
$1.93
EPS Est.
$1.92
EPS Surpr.
+0.5%
Revenue
$0.73B
Q3 FY2024
Aug 15, 2024Miss
EPS Actual
$1.68
EPS Est.
$2.07
EPS Surpr.
-18.8%
Revenue
$0.76B
Q1 FY2024
Feb 18, 2024Beat
EPS Actual
$1.98
EPS Est.
$1.95
EPS Surpr.
+1.5%
Revenue
$0.76B
Q2 FY2023
Jun 30, 2023Miss
EPS Actual
$1.60
EPS Est.
$1.63
EPS Surpr.
-1.8%
Revenue
$0.71B
Q4 FY2022
Dec 31, 2022Beat
EPS Actual
$1.47
EPS Est.
$1.44
EPS Surpr.
+2.1%
Revenue
$0.61B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $3.10 | $3.10 | $3.10 | 1 |
| Q3 FY2025 | $0.00 | $0.00 | $0.00 | 0 |
| Q2 FY2025 | $2.94 | $2.94 | $2.94 | 1 |
| Q2 FY2024 | $3.06 | $3.06 | $3.06 | 1 |
| Q4 FY2023 | $2.39 | $2.39 | $2.39 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2025 | $1.8B | $1.8B | $1.8B | 1 |
| Q3 FY2025 | $1.2B | $1.2B | $1.2B | 1 |
| Q2 FY2025 | $1.8B | $1.8B | $1.8B | 1 |
| Q2 FY2024 | $1.8B | $1.8B | $1.8B | 1 |
| Q4 FY2023 | $1.5B | $1.5B | $1.5B | 1 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q1 FY2026 | Feb 12, 2026 | -5.2% | $180.67 | $180.67 | +0.00% |
| ▼ Q3 FY2025 | Aug 13, 2025 | -5.7% | $193.88 | $193.88 | +0.00% |
| ▲ Q1 FY2025 | Feb 13, 2025 | +0.5% | $184.89 | $184.89 | +0.00% |
| ▼ Q3 FY2024 | Aug 15, 2024 | -18.8% | $235.10 | $235.10 | +0.00% |
| ▲ Q1 FY2024 | Feb 18, 2024 | +1.5% | $215.75 | $220.00 | +1.97% |
| ▼ Q2 FY2023 | Jun 30, 2023 | -1.8% | $151.89 | $150.25 | -1.08% |
| ▲ Q4 FY2022 | Dec 31, 2022 | +2.1% | $135.00 | $135.00 | +0.00% |
| ▲ Q2 FY2022 | Jun 30, 2022 | -0.8% | $135.25 | $135.63 | +0.28% |
Q1 FY2026+0.00%
Report Date
Feb 12, 2026
EPS Beat/Miss
-5.2%
Price Before
$180.67
Price After
$180.67
Q3 FY2025+0.00%
Report Date
Aug 13, 2025
EPS Beat/Miss
-5.7%
Price Before
$193.88
Price After
$193.88
Q1 FY2025+0.00%
Report Date
Feb 13, 2025
EPS Beat/Miss
+0.5%
Price Before
$184.89
Price After
$184.89
Q3 FY2024+0.00%
Report Date
Aug 15, 2024
EPS Beat/Miss
-18.8%
Price Before
$235.10
Price After
$235.10
Q1 FY2024+1.97%
Report Date
Feb 18, 2024
EPS Beat/Miss
+1.5%
Price Before
$215.75
Price After
$220.00
Q2 FY2023-1.08%
Report Date
Jun 30, 2023
EPS Beat/Miss
-1.8%
Price Before
$151.89
Price After
$150.25
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
+2.1%
Price Before
$135.00
Price After
$135.00
Q2 FY2022+0.28%
Report Date
Jun 30, 2022
EPS Beat/Miss
-0.8%
Price Before
$135.25
Price After
$135.63
Avg Beat Reaction+0.56%
Avg Miss Reaction-0.27%
Beat Rate4 / 8 quarters
Largest Move+1.97% (Q1 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CHEOF ends December
Cochlear Limited (CHEOF) most recently reported earnings on February 12, 2026 for Q1 FY2026, posting EPS of $1.99 — missing the analyst consensus of $2.10 by -5.2%. The next CHEOF earnings date is expected around September 1, 2026.
Each quarter, investors track CHEOF earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CHEOF revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CHEOF's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CHEOF earnings · 5 questionsCochlear Limited's next earnings report is expected around September 1, 2026. CHEOF typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CHEOF historically reports after market close (AMC).
CHEOF earnings datewhen is CHEOF earningsCHEOF next earnings datewhen does CHEOF report earningsCHEOF earnings calendar
▸ Source: FMP · Cochlear Limited SEC filings · US GAAP · Cochlear Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026